These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
517 related articles for article (PubMed ID: 22607702)
61. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor). Inada S; Koto T; Futami K; Arima S; Iwashita A Surg Today; 1999; 29(6):493-503. PubMed ID: 10385363 [TBL] [Abstract][Full Text] [Related]
62. Expression of cytokeratin subtypes: MMP-9, p53, and αSMA to differentiate basaloid squamous cell carcinoma from other basaloid tumors of the oral cavity. Mane DR; Kale AD; Angadi P; Hallikerimath S Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):431-43. PubMed ID: 23343955 [TBL] [Abstract][Full Text] [Related]
63. EGFR and MYC gene copy number aberrations are more common in squamous cell carcinoma than keratoacanthoma: a FISH study. Jacobs MS; Persons DL; Fraga GR J Cutan Pathol; 2013 May; 40(5):447-54. PubMed ID: 23521519 [TBL] [Abstract][Full Text] [Related]
64. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Itakura Y; Sasano H; Shiga C; Furukawa Y; Shiga K; Mori S; Nagura H Cancer; 1994 Aug; 74(3):795-804. PubMed ID: 8039107 [TBL] [Abstract][Full Text] [Related]
65. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis. Sarbia M; Verreet P; Bittinger F; Dutkowski P; Heep H; Willers R; Gabbert HE Cancer; 1997 May; 79(10):1871-8. PubMed ID: 9149011 [TBL] [Abstract][Full Text] [Related]
66. Clinicopathological analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma. Patil DT; Goldblum JR; Billings SD Mod Pathol; 2013 Oct; 26(10):1382-9. PubMed ID: 23599161 [TBL] [Abstract][Full Text] [Related]
67. [Analysis of epidermal growth factor receptor expression and gene expression status in tissue microarray of cervical squamous cell carcinoma]. Zhou SY; Feng GF; Chen GR; Pan D; Zhang PN; Yang XM; Xia ZL Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):843-6. PubMed ID: 24444562 [TBL] [Abstract][Full Text] [Related]
68. Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study. Huang J; Fan Q; Lu P; Ying J; Ma C; Liu W; Liu Y; Tan F; Sun Y J Thorac Oncol; 2016 Jun; 11(6):910-7. PubMed ID: 26980473 [TBL] [Abstract][Full Text] [Related]
69. Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Esteve A; Lehman T; Jiang W; Weinstein IB; Harris CC; Ruol A; Peracchia A; Montesano R; Hollstein M Mol Carcinog; 1993; 8(4):306-11. PubMed ID: 8280379 [TBL] [Abstract][Full Text] [Related]
70. Determination of HER2 and p53 Mutations by Sequence Analysis Method and EGFR/Chromosome 7 Gene Status by Fluorescence in Situ Hybridization for the Predilection of Targeted Therapy Modalities in Immunohistochemically Triple Negative Breast Carcinomas in Turkish Population. Pala EE; Bayol U; Keskin EU; Ozguzer A; Kucuk U; Ozer O; Koc A Pathol Oncol Res; 2015 Sep; 21(4):1223-7. PubMed ID: 26060045 [TBL] [Abstract][Full Text] [Related]
71. Warty-basaloid carcinoma: clinicopathological features of a distinctive penile neoplasm. Report of 45 cases. Chaux A; Tamboli P; Ayala A; Soares F; Rodríguez I; Barreto J; Cubilla AL Mod Pathol; 2010 Jun; 23(6):896-904. PubMed ID: 20305615 [TBL] [Abstract][Full Text] [Related]
72. Downregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma. Saito T; Mitomi H; Imamhasan A; Hayashi T; Mitani K; Takahashi M; Kajiyama Y; Yao T Virchows Arch; 2014 Feb; 464(2):135-43. PubMed ID: 24464051 [TBL] [Abstract][Full Text] [Related]
73. Esophageal squamous cell carcinoma with basaloid features are genetically and prognostically similar to conventional squamous cell carcinoma. Sauer MA; Yang J; Isidro RA; Dong F; Patil DT; Wee JO; Agoston AT; Deshpande V; Zhao L Mod Pathol; 2022 Sep; 35(9):1247-1253. PubMed ID: 35351978 [TBL] [Abstract][Full Text] [Related]
74. TP53 gene deletion in esophageal cancer tissues of patients and its clinical significance. Niyaz M; Turghun A; Ping ZH; Zhu Z; Sheyhedin I; Ren C; Awut I Mol Med Rep; 2013 Jan; 7(1):122-6. PubMed ID: 23128792 [TBL] [Abstract][Full Text] [Related]